Although it has been found that the overexpression of SLC2A1 can further the glycolysis process and cell proliferation of CRC (Shen et al., 2020; Chen et al., 2021), the biological function of SLC2A1 in CRC has not been extensively studied. The gene discussed is SLC2A1; the disease is colorectal carcinoma.